The temperature requirements for Covid-19 vaccines have focused attention on the cold chain, with nearly 6x more earnings calls mentions vs. last year. Here are the top-line bullets you need to know.
Cold chain — a suite of technologies and processes that are used to preserve integrity across manufacturing, storage, and transportation for temperature-sensitive products — has captured executive attention as Covid-19 vaccine distribution is top-of-mind.
WHAT YOU NEED TO KNOW:
- Executives focus on vaccine distribution: Executive discussion regarding the pharmaceutical cold chain hit new heights in Q4’20, as Covid-19 vaccines neared and received FDA emergency use authorization. Companies including Cardinal Health, Brooks Automation, and UPS are discussing their preparation and readiness for temperature-controlled vaccine distribution.
- Cold chain is a hotspot for internet-of-things (IoT) and artificial intelligence (AI) tech: Among emerging technologies, IoT and AI have gained traction in the cold chain. A leading use case here is anomaly detection for identifying and mitigating temperature risks during transportation. For example, Pfizer is using Controlant’s sensors and data visibility platform for its vaccine distribution.